Patenting Health: You Cannot Own the Laws of Nature
On March 20, 2012, the United States Supreme Court decided Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S. Ct. 1289 (U.S. 2012). The case
On March 20, 2012, the United States Supreme Court decided Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S. Ct. 1289 (U.S. 2012). The case
This Wednesday, April 18, Pfizer will defend the patent protecting the little blue pill that has changed the lives of men and women around the
Three years ago, the Federal Court announced a plan to try to schedule trials within two years of the commencement of the proceeding. Since that
The Copyright Modernization Act (Bill C-11) has generated much discussion on its merits and deficiencies. However, one issue that commentators have not discussed in depth
The Canadian government and European Union (EU) are currently negotiating a Comprehensive Economic and Trade Agreement (CETA). A key issue has been ensuring that Canadian
In a move with far reaching implications for the debates around pharmaceutical patents, innovation and access to medicines, the Indian patent office issued its first